BRAF and neoplasm: Compared to BRAF-negative patients, BRAF-positive patients were more likely to be male (21.8% vs. 14.6%, P = 0.028) and to have a larger pathologic tumor size (9.1±5.9 mm vs. 6.6±4.2 mm, P<0.0001).